Cardiovascular adverse events in multiple myeloma patients
Multiple myeloma is a malignant disease, caused by an uncontrolled clonal proliferation of a specific group of white blood cells, the plasma cells. Clinical manifestations include bone pain due to osteolysis, hypercalcemia, anemia, and renal insufficiency. Proteasome inhibitors have substantially im...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
Sep 18, 2018
|
| In: |
Journal of thoracic disease
Year: 2018, Jahrgang: 10, Pages: S4296-S4305 |
| ISSN: | 2077-6624 |
| DOI: | 10.21037/jtd.2018.09.87 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.21037/jtd.2018.09.87 Verlag: http://jtd.amegroups.com/article/view/24530 |
| Verfasserangaben: | Markus B. Heckmann, Shirin Doroudgar, Hugo A. Katus, Lorenz H. Lehmann |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1679445286 | ||
| 003 | DE-627 | ||
| 005 | 20230426135150.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191023s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.21037/jtd.2018.09.87 |2 doi | |
| 035 | |a (DE-627)1679445286 | ||
| 035 | |a (DE-599)KXP1679445286 | ||
| 035 | |a (OCoLC)1341249096 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Heckmann, Markus B. |d 1986- |e VerfasserIn |0 (DE-588)1120448077 |0 (DE-627)873392434 |0 (DE-576)480359253 |4 aut | |
| 245 | 1 | 0 | |a Cardiovascular adverse events in multiple myeloma patients |c Markus B. Heckmann, Shirin Doroudgar, Hugo A. Katus, Lorenz H. Lehmann |
| 264 | 1 | |c Sep 18, 2018 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.10.2019 | ||
| 520 | |a Multiple myeloma is a malignant disease, caused by an uncontrolled clonal proliferation of a specific group of white blood cells, the plasma cells. Clinical manifestations include bone pain due to osteolysis, hypercalcemia, anemia, and renal insufficiency. Proteasome inhibitors have substantially improved survival of patients suffering from multiple myeloma, providing an efficient treatment option mainly for relapsed and refractory multiple myeloma. Although constituting one substance class, bortezomib, carfilzomib, and ixazomib differ greatly regarding their non-hematologic side effects. This article reviews the clinical and preclinical data on approved proteasome inhibitors in an attempt to decipher the underlying pathomechanisms related to cardiovascular adverse events seen in clinical trials. | ||
| 700 | 1 | |a Doroudgar, Shirin |e VerfasserIn |0 (DE-588)1139390260 |0 (DE-627)897138023 |0 (DE-576)493250972 |4 aut | |
| 700 | 1 | |a Katus, Hugo |d 1951- |e VerfasserIn |0 (DE-588)108916618 |0 (DE-627)577155040 |0 (DE-576)289625076 |4 aut | |
| 700 | 1 | |a Lehmann, Lorenz |d 1980- |e VerfasserIn |0 (DE-588)131855212 |0 (DE-627)515807184 |0 (DE-576)298796104 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of thoracic disease |d Hong Kong : AME Publishing Company, 2009 |g 10(2018, Supplement 35), 10 Seiten |h Online-Ressource |w (DE-627)635603896 |w (DE-600)2573571-8 |w (DE-576)330413570 |x 2077-6624 |7 nnas |a Cardiovascular adverse events in multiple myeloma patients |
| 773 | 1 | 8 | |g volume:10 |g year:2018 |g supplement:Supplement 35 |g pages:S4296-S4305 |g extent:10 |a Cardiovascular adverse events in multiple myeloma patients |
| 856 | 4 | 0 | |u https://doi.org/10.21037/jtd.2018.09.87 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u http://jtd.amegroups.com/article/view/24530 |x Verlag |
| 951 | |a AR | ||
| 992 | |a 20191023 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 131855212 |a Lehmann, Lorenz |m 131855212:Lehmann, Lorenz |d 910000 |d 910100 |e 910000PL131855212 |e 910100PL131855212 |k 0/910000/ |k 1/910000/910100/ |p 4 |y j | ||
| 998 | |g 108916618 |a Katus, Hugo |m 108916618:Katus, Hugo |d 910000 |d 910100 |e 910000PK108916618 |e 910100PK108916618 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 1139390260 |a Doroudgar, Shirin |m 1139390260:Doroudgar, Shirin |d 910000 |d 910100 |e 910000PD1139390260 |e 910100PD1139390260 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 1120448077 |a Heckmann, Markus B. |m 1120448077:Heckmann, Markus B. |d 910000 |d 910100 |e 910000PH1120448077 |e 910100PH1120448077 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1679445286 |e 3526315698 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Markus B. Heckmann, Shirin Doroudgar, Hugo A. Katus, Lorenz H. Lehmann"]},"language":["eng"],"note":["Gesehen am 23.10.2019"],"recId":"1679445286","origin":[{"dateIssuedDisp":"Sep 18, 2018","dateIssuedKey":"2018"}],"person":[{"display":"Heckmann, Markus B.","family":"Heckmann","given":"Markus B.","role":"aut"},{"display":"Doroudgar, Shirin","family":"Doroudgar","given":"Shirin","role":"aut"},{"family":"Katus","display":"Katus, Hugo","role":"aut","given":"Hugo"},{"role":"aut","given":"Lorenz","family":"Lehmann","display":"Lehmann, Lorenz"}],"id":{"eki":["1679445286"],"doi":["10.21037/jtd.2018.09.87"]},"physDesc":[{"extent":"10 S."}],"relHost":[{"recId":"635603896","language":["eng"],"note":["Gesehen am 10.11.25"],"origin":[{"dateIssuedDisp":"2015-","publisher":"AME Publishing Company ; Pioneer Bioscience Publ.","dateIssuedKey":"2015","publisherPlace":"Hong Kong ; Hong Kong"}],"pubHistory":["1.2009 -"],"part":{"text":"10(2018, Supplement 35), 10 Seiten","year":"2018","volume":"10","pages":"S4296-S4305","extent":"10"},"titleAlt":[{"title":"JTD"}],"disp":"Cardiovascular adverse events in multiple myeloma patientsJournal of thoracic disease","id":{"issn":["2077-6624"],"eki":["635603896"],"zdb":["2573571-8"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Journal of thoracic disease","title_sort":"Journal of thoracic disease"}]}],"title":[{"title":"Cardiovascular adverse events in multiple myeloma patients","title_sort":"Cardiovascular adverse events in multiple myeloma patients"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a HECKMANNMACARDIOVASC1820 | ||